Please login to the form below

Brandcast Health celebrates more major awards

Brandcast Health, the UK’s leading digital agency in cancer education and communications, has taken home two more awards to add to this year’s tally.

Partnering with Patient Power across Europe, the education and empowerment online channel for cancer  patients and caregivers, Brandcast Health has won the 2016 EVCOM CLARION awards for Digital Events (silver) and for Community Engagement and Social Enterprise(gold).

These latest accolades follow on from Brandcast Health winning the 2016 Communique award for Excellence in Digital Patient Communication.

In addition, Brandcast and Patient Power’s founder Andrew Schorr, a two-time cancer survivor, have also been announced as joint finalists in this year’s prestigious PMEA awards. This award category marks the importance of the patient in today’s healthcare environment, highlighting activities that have brought significant benefits to specific groups of patients to support and maintain understanding and management of their condition.

These latest awards follow several years of success for the agency in digital communications in the cancer sector and in the wider world of patient engagement and medical education in pharma, biotech and hospital care.

Brandcast CEO, Charlie Grieve, said “the latest wins reflected the agency’s policy of building a team of top medical digital specialists, with the empathy and total understanding of the needs of cancer patients and their families.”

“We have a highly qualified team, who recognise that patients increasingly demand a much greater involvement in the management of their treatment.  Perceptive, innovative and efficient digital communications is a proven and vital tool helping patients, doctors, hospitals and pharma work as a team to achieve the best possible outcomes,” he said.

“Patients’ needs and demands to learn more, and be part of the decision-making process, have changed dramatically in recent years, and not before time.  When you have intuitive and pioneering partners, such as Patient Power, it is tremendously satisfying to be able to help make a real difference to people’s lives.”

For more information about the awards and Brandcast Health, please call Charlie Grieve or Stephen Dunn on +44 207 291 5070

17th November 2016


Company Details

Brandcast Health

+44 (0)20 7291 5070

Contact Website

16-17 Little Portland Street

Latest content on this profile

Day 2 Round-up from the Giant Health Event
Robin gives a quick overview of day 2 of the Giant Health Event.
Brandcast Health
Why patient education is important in oncology
We talked to Dr Bettina Ryll of Melanoma Patient Network Europe about changes in melanoma treatment and how the added complexity of new treatments has changed how patients need to be informed.
Brandcast Health
CABOSUN trial of cabozantinib – could it change how we treat frontline renal-cell carcinoma?
In the CABOSUN trial, cabozantinib was compared to sunitinib in treatment naive poor and intermediate risk renal-cell carcinoma (RCC) patients.
Brandcast Health
No surprises: results from the ENGOT-OV16/NOVA trial of niraparib in ovarian cancer
The ENGOT-OV16/NOVA trial of niraparib was a randomized, double-blinded placebo study with women with relapsed platinum-sensitive high-grade ovarian cancer.
Brandcast Health
FALCON trial of fulvestrant for advanced breast cancer
The Phase III FALCON trial compared fulvestrant to anastrozole for hormone receptor-positive advanced breast cancer.
Brandcast Health
Overview of the GIANT Health Event
Shafi Ahmed, PhD, FRCS, Director of Virtual Medics and Medical and GIANT Event Co-chair, provides an overview of the GIANT Health Event.
Brandcast Health